Mark Frasier

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

Kenneth Marek, Sohini Chowdhury, Andrew Siderowf et al. · Annals of Clinical and Translational Neurology · 2018 · 633 citations · Full text

Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study

Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant et al. · The Lancet Neurology · 2023 · 618 citations · Full text

Neurodegenerative Diseases, Disease Progression, Parkinson Disease +4

Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease

Kuldip D. Dave, Shehan De Silva, Niketa P. Sheth et al. · Neurobiology of Disease · 2014 · 225 citations · Full text

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

Mike A. Nalls, Cory Y. McLean, Jacqueline Rick et al. · The Lancet Neurology · 2015 · 216 citations · Full text

Disease Diagnosis, Neurological Disorder, Medicine +13

Magnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein

Natalie Golts, Heather M. Snyder, Mark Frasier et al. · Journal of Biological Chemistry · 2002 · 209 citations · Full text